E854-0193 Screening compound: N-{3-[3,4-dihydro-2(1H)-isoquinolinyl]propyl}-2-(3,4-dimethyl-7-oxo-2-phenyl-2,7-dihydro-6H-pyrazolo[3,4-d]pyridazin-6-yl)acetamide

E854-0193 Screening compound: N-{3-[3,4-dihydro-2(1H)-isoquinolinyl]propyl}-2-(3,4-dimethyl-7-oxo-2-phenyl-2,7-dihydro-6H-pyrazolo[3,4-d]pyridazin-6-yl)acetamide
E854-0193 Screening compound: N-{3-[3,4-dihydro-2(1H)-isoquinolinyl]propyl}-2-(3,4-dimethyl-7-oxo-2-phenyl-2,7-dihydro-6H-pyrazolo[3,4-d]pyridazin-6-yl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E854-0193
N-{3-[3,4-dihydro-2(1H)-isoquinolinyl]propyl}-2-(3,4-dimethyl-7-oxo-2-phenyl-2,7-dihydro-6H-pyrazolo[3,4-d]pyridazin-6-yl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E854-0193

Molecular Formula

C27H30N6O2 (C27 H30 N6 O2)

Compound Name

N-{3-[3,4-dihydro-2(1H)-isoquinolinyl]propyl}-2-(3,4-dimethyl-7-oxo-2-phenyl-2,7-dihydro-6H-pyrazolo[3,4-d]pyridazin-6-yl)acetamide

IUPAC name

2-{34-dimethyl-7-oxo-2-phenyl-2H6H7H-pyrazolo[34-d]pyridazin-6-yl}-N-[3-(1234-tetrahydroisoquinolin-2-yl)propyl]acetamide

SMILES

Cc(n(-c1ccccc1)nc12)c2C(C)=NN(CC(NCCCN(CC2)Cc3c2cccc3)=O)C1=O

InChI

InChI=1S/C27H30N6O2/c1-19-25-20(2)33(23-11-4-3-5-12-23)30-26(25)27(35)32(29-19)18-24(34)28-14-8-15-31-16-13-21-9-6-7-10-22(21)17-31/h3-7,9-12H,8,13-18H2,1-2H3,(H,28,34)

InChI Key

OFVCQDGZFAYGNO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14922722

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

470.57

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.535

Distribution Coefficient, logD

1.331

Water Solubility, LogSw

-2.69

Polar Surface Area

69.300

Acid Dissociation Constant (pKa)

16.11

Base Dissociation Constant (pKb)

8.58

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

33.33

E854-0193 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Protein-Protein Interaction Library (218420 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • Receptor's ligands

References: we are preparing a list of scientific research reports with E854-0193 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E854-0193?
Check Price and Availability of E854-0193, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E854-0193 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E854-0193
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E854-0193
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E854-0193 available by request